Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques

被引:6
|
作者
Cho, Galaxy Y. [1 ,2 ,3 ,4 ]
Bolo, Kyle [5 ]
Park, Karen Sophia [1 ,2 ,3 ]
Sengillo, Jesse D. [6 ]
Tsang, Stephen H. [1 ,2 ,3 ,5 ,7 ,8 ]
机构
[1] Jonas Childrens Vis Care, New York, NY 10032 USA
[2] Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10032 USA
[3] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA
[4] Quinnipiac Univ, Frank H Netter MD Sch Med, North Haven, CT USA
[5] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10032 USA
[6] Reading Hosp, Dept Internal Med, W Reading, PA USA
[7] Inst Human Nutr, Dept Pathol & Cell Biol, Stem Cell Initiat CSCI, New York, NY 10032 USA
[8] Columbia Univ, Med Ctr, Harkness Eye Inst, 635 West 165th St,Box 212, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
LEBER CONGENITAL AMAUROSIS; HEREDITARY OPTIC NEUROPATHY; ADENOASSOCIATED VIRUS; MACULAR DEGENERATION; SUBRETINAL INJECTION; RETINITIS-PIGMENTOSA; RPE65; MUTATIONS; IMMUNE-RESPONSE; OPEN-LABEL; FOLLOW-UP;
D O I
10.1007/s40291-018-0377-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Inherited retinal dystrophies cause progressive vision loss and are major contributors to blindness worldwide. Advances in gene therapy have brought molecular approaches into the realm of clinical trials for these incurable illnesses. Select phase I, II and III trials are complete and provide some promise in terms of functional outcomes and safety, although questions do remain over the durability of their effects and the prevalence of inflammatory reactions. This article reviews gene therapy as it can be applied to inherited retinal dystrophies, provides an update of results from recent clinical trials, and discusses the future prospects of gene therapy and genome surgery.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 50 条
  • [1] Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques
    Galaxy Y. Cho
    Kyle Bolo
    Karen Sophia Park
    Jesse D. Sengillo
    Stephen H. Tsang
    Molecular Diagnosis & Therapy, 2019, 23 : 113 - 120
  • [2] Gene-Based Therapeutics for Inherited Retinal Diseases
    Fenner, Beau J.
    Tan, Tien-En
    Barathi, Amutha Veluchamy
    Tun, Sai Bo Bo
    Yeo, Sia Wey
    Tsai, Andrew S. H.
    Lee, Shu Yen
    Cheung, Chui Ming Gemmy
    Chan, Choi Mun
    Mehta, Jodhbir S.
    Teo, Kelvin Y. C.
    FRONTIERS IN GENETICS, 2022, 12
  • [3] Role of Translational Attenuation in Inherited Retinal Degeneration
    Starr, Christopher R.
    Nyankerh, Cyril N. A.
    Qi, Xiaoping
    Hu, Yang
    Gorbatyuk, Oleg S.
    Sonenberg, Nahum
    Boulton, Michael E.
    Gorbatyuk, Marina S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (14) : 4849 - 4857
  • [4] Conference summary - Gene-based therapies for inherited and acquired disorders of the lung
    Curiel, DT
    CHEST, 1997, 111 (06) : S149 - S152
  • [5] Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress
    Tan, Tien-En
    Fenner, Beau James
    Barathi, Veluchamy Amutha
    Tun, Sai Bo Bo
    Wey, Yeo Sia
    Tsai, Andrew Shih Hsiang
    Su, Xinyi
    Lee, Shu Yen
    Cheung, Chui Ming Gemmy
    Wong, Tien Yin
    Mehta, Jodhbir Singh
    Teo, Kelvin Yi Chong
    FRONTIERS IN GENETICS, 2021, 12
  • [6] Gene therapy for inherited retinal degeneration
    Ali, RR
    Sarra, GM
    Stephens, CM
    de Alwis, M
    Bainbridge, JWB
    Thrasher, AJ
    JOURNAL OF MEDICAL GENETICS, 2001, 38 : S26 - S26
  • [7] Gene therapy for inherited retinal degeneration
    Ali, RR
    Reichel, MB
    Hunt, DM
    Bhattacharya, SS
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (09) : 795 - 801
  • [8] Gene therapy for inherited retinal degeneration
    Ali, RR
    JOURNAL OF GENE MEDICINE, 2003, 5 (03): : S6 - S7
  • [9] Gene Therapy for Inherited Retinal Degeneration
    Arbabi, Amirmohsen
    Liu, Amelia
    Ameri, Hossein
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 35 (02) : 79 - 97
  • [10] Gene-based therapies for dominantly inherited retinopathies
    G J Farrar
    S Millington-Ward
    N Chadderton
    P Humphries
    P F Kenna
    Gene Therapy, 2012, 19 : 137 - 144